"We are so grateful to Mastercard for their ceaseless commitment to Stand Up To Cancer. It is because of the incredible support we receive from Mastercard and their consumers that Stand Up To Cancer is able to carry out the accelerated cancer research programs that are helping to save more lives," said Stand Up To Cancer co-founder Rusty Robertson. "During this year's season of giving, everyone can help, through the simple acts of seeing a movie with loved ones, or making a donation."The donations driven by Mastercard and its generous cardholders have helped provide support for translational cancer research conducted in the Stand Up To Cancer model. For more information about the company's support for SU2C, visit http://www.standup2cancer.org/supporters/visionaries. About Mastercard Mastercard (NYSE: MA), www.mastercard.com, is a technology company in the global payments industry. We operate the world's fastest payments processing network, connecting consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. Mastercard products and solutions make everyday commerce activities - such as shopping, traveling, running a business and managing finances - easier, more secure and more efficient for everyone. Follow us on Twitter @MastercardNews, join the discussion on the Beyond the Transaction Blog and subscribe for the latest news on the Engagement Bureau. About the Stand Up To Cancer Initiative Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in the United States in 2008 by film and media leaders who utilize the industry's resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease. As SU2C's scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, PhD, conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren, and Kathleen Lobb. Noreen Fraser and the late Laura Ziskin are also co-founders. Sung Poblete, Ph.D., R.N., has served as SU2C's president since 2011.For more information about Stand Up To Cancer, visit: www.standup2cancer.org.